The research reported in this publication was supported by Breakthrough T1D, Clinicaltrials.gov number NCT05537233.
You can get more information there that matches your medical history and health goals
Semaglutide is not currently approved for the treatment of type 1 diabetes, and its safety and efficacy in this population have not been established
Average body weight loss in clinical trials Once-weekly injection, fits into your routine Added B12 support, may help sustain energy Compounded medications, while permitted under federal law, are not approved by the FDA
Theres evidence that these drugs affect the gut-brain axis, he adds, which might influence motility in more complex ways, but the main culprit is delayed gastric emptying. The gut-brain axis is the information superhighway between your gut and your brain